Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fluconazole - oral capsule - 50mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - fluconazole - oral capsule - 150mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - fluconazole - oral capsule - 50mg

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 50 microgram/ml - oral liquid - excipient ingredients: methyl hydroxybenzoate; dibasic sodium phosphate heptahydrate; sucrose; citric acid; ethanol; propylene glycol; quinoline yellow; purified water; flavour - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 200 mg/ml;   - powder for oral suspension - 200 mg/ml - active: mycophenolate mofetil 200 mg/ml   excipient: aspartame citric acid colloidal silicon dioxide fruit mix flavour 274869 lecithin methyl hydroxybenzoate sodium citrate dihydrate sorbitol xanthan gum - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Israel - engelska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - voriconazole - powder for solution for infusion - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. - treatment of candidemia in non neutropenic patients.- prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

Irland - engelska - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - losartan potassium - powder for oral suspension - 2.5 milligram(s)/millilitre - angiotensin ii antagonists, plain; losartan

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - fluconazole - oral capsule - 50mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - fluconazole - oral capsule - 150mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - fluconazole - oral capsule - 50mg